Gregory L. Damhorst, MD, PhD

Recent Publications

  1. Farmer S, Razin V, Peagler AF, Strickler S, Fain WB, Damhorst GL, Kempker RR, Pollock NR, Brand O, Seitter B, Heilman SS, Nehl EJ, Levy JM, Gottfried DS, Martin GS, Greenleaf M, Ku DN, Waggoner JJ, Iffrig E, Mannino R, Wang YF, Ortlund E, Sullivan J, Rebolledo PA, ClaverĂ­a V, Roback JD, Benoit M, Stone C, Esper A, Frank F, Lam WA. Don't Forget About Human Factors: Lessons Learned from COVID-19 Point-of-Care Testing. Cell Rep Methods. 2022 May 3:100222. doi: 10.1016/j.crmeth.2022.100222. Epub ahead of print. PMID: 35527805; PMCID: PMC9061138.

  2. Greenleaf MN, Damhorst GL, Ku DN, Nehl EJ, Tyburski EA, Brand O, Martin GS, Lam WA. Designing for simplicity: lessons from Mesa Biotech for microfluidic entrepreneurs and early-stage companies. Lab Chip. 2022 Apr 12;22(8):1469-1473. doi: 10.1039/d2lc00081d. PMID: 35342919; PMCID: PMC9012986.

  3. Damhorst GL, Watts A, Hernandez-Romieu A, Mel N, Palmore M, Ali IKM, Neill SG, Kalapila A, Cope JR. Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature review. Lancet Infect Dis. 2022 Feb;22(2):e59-e65. doi: 10.1016/S1473-3099(20)30933-6. Epub 2021 Aug 27. PMID: 34461057.

  4. Damhorst GL, Broder KJ, Overton EC, Rara R, Busch LM, Burd EM, Webster AS, Kraft CS, Babiker A. Clinical Utilization of DiaSorin Molecular Polymerase Chain Reaction in Pneumocystis Pneumonia. Open Forum Infect Dis. 2022 Jan 10;9(1):ofab634. doi: 10.1093/ofid/ofab634. PMID: 35036467; PMCID: PMC8754379.

  5. Taneja I*, Damhorst GL*, Lopez-Espina C, Zhao SD, Zhu R, Khan S, White K, Kumar J, Vincent A, Yeh L, Majdizadeh S, Weir W, Isbell S, Skinner J, Devanand M, Azharuddin S, Meenakshisundaram R, Upadhyay R, Syed A, Bauman T, Devito J, Heinzmann C, Podolej G, Shen L, Timilsina SS, Quinlan L, Manafirasi S, Valera E, Reddy B Jr, Bashir R. Diagnostic and prognostic capabilities of a biomarker and EMR-based machine learning algorithm for sepsis. Clin Transl Sci. 2021 Jul;14(4):1578-1589. doi: 10.1111/cts.13030. Epub 2021 May 2. PMID: 33786999; PMCID: PMC8301583.

  6. Damhorst GL, Adelman MW, Woodworth MH, Kraft CS. Current Capabilities of Gut Microbiome-Based Diagnostics and the Promise of Clinical Application. J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S270-S275. doi: 10.1093/infdis/jiaa689. PMID: 33330938; PMCID: PMC8206793.

  7. Damhorst GL, Tyburski EA, Brand O, Martin GS, Lam WA. Diagnosis of acute serious illness: the role of point-of-care technologies. Curr Opin Biomed Eng. 2019 Sep;11:22-34. doi: 10.1016/j.cobme.2019.08.012. Epub 2019 Sep 16. PMID: 34079919; PMCID: PMC8168915.

*Shared first author

See all publications